tDCS + Cognitive Training for Stroke
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores new methods to help stroke survivors improve daily activities. It combines brain stimulation (tDCS, a gentle electrical treatment) with cognitive exercises to assess its potential to enhance recovery. Participants will join groups testing different combinations of these treatments, including CO-OP Procedures, a therapy focused on improving daily activities. The trial suits individuals over six months post-stroke, not currently in therapy, and with specific personal recovery goals. The researchers aim to refine the protocol and estimate the treatment's impact on activity performance. As an unphased trial, it provides a unique opportunity to contribute to innovative stroke recovery research.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that transcranial direct current stimulation (tDCS) is generally safe and well-tolerated for people recovering from a stroke. In earlier studies, participants reported only mild side effects, such as tingling or itching where the device was applied. These effects were temporary and not serious.
Safety reviews for the CO-OP (Cognitive Orientation to daily Occupational Performance) procedures combined with tDCS indicate that this combination does not cause severe side effects. Most people manage any mild discomfort without problems.
Regarding computer-based cognitive training with tDCS, studies suggest it is also safe. Participants have experienced similar mild, temporary side effects, such as slight headaches or skin redness. Overall, both treatments are considered safe for use in stroke rehabilitation.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores the potential of combining transcranial direct current stimulation (tDCS) with cognitive training to enhance recovery after a stroke. Unlike conventional treatments like physical therapy or medication that mainly address physical or biochemical aspects, this approach targets the brain's electrical activity to boost cognitive function. By applying anodal tDCS to the left dorsolateral prefrontal cortex, researchers aim to enhance brain plasticity and improve learning and memory in stroke patients. This could lead to more effective and faster cognitive recovery, providing a unique avenue for rehabilitation beyond current methods.
What evidence suggests that this trial's treatments could be effective for stroke?
Research shows that a gentle electrical treatment called transcranial direct current stimulation (tDCS), combined with mental exercises, can aid stroke recovery. In this trial, participants will join different groups to receive either tDCS or sham tDCS with mental exercises. Studies have found that tDCS improves language skills and thinking abilities after a stroke. Applying tDCS to the brain enhances the effectiveness of rehabilitation exercises. When paired with mental exercises, such as computer-based programs, tDCS has enhanced thinking skills and everyday abilities. These findings suggest that tDCS with mental exercises could provide additional benefits for stroke recovery.56789
Who Is on the Research Team?
Anna E Boone, PhD, OTR/L
Principal Investigator
University of Missouri Occupational Therapy
Are You a Good Fit for This Trial?
This trial is for individuals who had an ischemic stroke at least 6 months ago, are not currently in therapy, and have at least four personal goals they want to achieve. People with severe depression, dementia symptoms, other neurological disorders, moderate to severe speech difficulties (aphasia), or any condition that makes tDCS unsafe cannot join.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either CO-OP with tDCS, computer cognitive training with tDCS, CO-OP with sham tDCS, or computer cognitive training with sham tDCS. Each session includes 20 minutes of tDCS or sham followed by 45 minutes of the assigned intervention.
Follow-up
Participants are monitored for safety and effectiveness after treatment, with assessments at 1-month post-intervention.
What Are the Treatments Tested in This Trial?
Interventions
- Computer Cognitive Training Procedures
- CO-OP Procedures
- sham tDCS group
- tDCS
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Missouri-Columbia
Lead Sponsor